Chlamydia muridarum Lung Infection in Infants Alters Hematopoietic Cells to Promote Allergic Airway Disease in Mice.

Related Articles

Chlamydia muridarum Lung Infection in Infants Alters Hematopoietic Cells to Promote Allergic Airway Disease in Mice.

PLoS One. 2012;7(8):e42588

Authors: Starkey MR, Kim RY, Beckett EL, Schilter HC, Shim D, Essilfie AT, Nguyen DH, Beagley KW, Mattes J, Mackay CR, Horvat JC, Hansbro PM

Abstract
BACKGROUND: Viral and bacterial respiratory tract infections in early-life are linked to the development of allergic airway inflammation and asthma. However, the mechanisms involved are not well understood. We have previously shown that neonatal and infant, but not adult, chlamydial lung infections in mice permanently alter inflammatory phenotype and physiology to increase the severity of allergic airway disease by increasing lung interleukin (IL)-13 expression, mucus hyper-secretion and airway hyper-responsiveness. This occurred through different mechanisms with infection at different ages. Neonatal infection suppressed inflammatory responses but enhanced systemic dendritic cell:T-cell IL-13 release and induced permanent alterations in lung structure (i.e., increased the size of alveoli). Infant infection enhanced inflammatory responses but had no effect on lung structure. Here we investigated the role of hematopoietic cells in these processes using bone marrow chimera studies.
METHODOLOGY/PRINCIPAL FINDINGS: Neonatal (<24-hours-old), infant (3-weeks-old) and adult (6-weeks-old) mice were infected with C. muridarum. Nine weeks after infection bone marrow was collected and transferred into recipient age-matched irradiated naïve mice. Allergic airway disease was induced (8 weeks after adoptive transfer) by sensitization and challenge with ovalbumin. Reconstitution of irradiated naïve mice with bone marrow from mice infected as neonates resulted in the suppression of the hallmark features of allergic airway disease including mucus hyper-secretion and airway hyper-responsiveness, which was associated with decreased IL-13 levels in the lung. In stark contrast, reconstitution with bone marrow from mice infected as infants increased the severity of allergic airway disease by increasing T helper type-2 cell cytokine release (IL-5 and IL-13), mucus hyper-secretion, airway hyper-responsiveness and IL-13 levels in the lung. Reconstitution with bone marrow from infected adult mice had no effects.
CONCLUSIONS: These results suggest that an infant chlamydial lung infection results in long lasting alterations in hematopoietic cells that increases the severity of allergic airway disease in later-life.

PMID: 22870337 [PubMed – in process]

View full post on pubmed: asthma

Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis.

Related Articles

Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis.

Allergy Asthma Proc. 2012 May-Jun;33(3):249-57

Authors: Meltzer EO, Jacobs RL, LaForce CF, Kelley CL, Dunbar SA, Tantry SK

Abstract
Intranasal corticosteroids are recommended as first-line therapy for the treatment of the symptoms of persistent allergic rhinitis (AR). Since the phase-out of chlorofluorocarbon nasal aerosols, intranasal corticosteroids have been available only as aqueous nasal sprays. This study was designed to assess the efficacy, safety, and quality-of-life benefits of beclomethasone dipropionate (BDP) hydrofluoroalkane nasal aerosol in subjects with perennial AR (PAR). After a 7- to 21-day placebo run-in period, eligible subjects aged â�¥12 years with PAR were randomized to 6 weeks of once-daily treatment with BDP nasal aerosol at 320 �¼g or placebo. Reflective and instantaneous total nasal symptom scores (rTNSS and iTNSS, respectively), Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score, and physician-assessed total nasal symptom score were evaluated. The primary end point was change from baseline in average morning (A.M.) and evening (P.M.) subject-reported rTNSS over the 6-week treatment period. Safety and tolerability were also assessed. Treatment with BDP nasal aerosol showed significantly greater improvement in average A.M. and P.M. rTNSS compared with placebo (mean treatment difference, -0.84; 95% confidence interval, -1.2, -0.5; p < 0.001). Greater improvements in rTNSS were reported as early as day 1 and were maintained throughout the 6-week treatment period with the exception of day 2. Greater improvements were seen for all four individual nasal symptoms (nasal congestion, nasal itching, rhinorrhea, and sneezing) with BDP nasal aerosol compared with placebo. Similarly, significant improvements were seen in average A.M. and P.M. iTNSS (p < 0.001) and RQLQ score (p = 0.001) with BDP nasal aerosol compared with placebo. In addition, BDP nasal aerosol treatment was well tolerated, and its safety profile was comparable to that of placebo. This clinical study indicated that treatment with BDP nasal aerosol provides statistically significant and clinically meaningful nasal symptom relief accompanied by improved quality of life in subjects with PAR. Additionally, treatment with BDP nasal aerosol was well tolerated with a safety profile comparable to that of placebo. This study was part of the clinical trial NCT01134705 registered in www.ClinicalTrials.gov.

PMID: 22737708 [PubMed – in process]

View full post on pubmed: asthma

Stress in Pregnant Women can Provoke Allergic Reactions Such as Asthma or … – MarketWatch (press release)

Stress in Pregnant Women can Provoke Allergic Reactions Such as Asthma or
MarketWatch (press release)
Exposure to allergens during pregnancy will be a key topic during the EAACI Congress, as well as how stress provokes reactions such us as asthma or eczema in the newborn. Japanese researchers have found that anxiety in pregnant woman is associated with

and more »

View full post on asthma – Google News

Actelion to end setipiprant clinical development in asthma, allergic rhinitis – RTT News

Actelion to end setipiprant clinical development in asthma, allergic rhinitis
RTT News
PK: News ) on Monday said two recently concluded studies with the first orally-active CRTH2 antagonist, setipiprant, in asthma and seasonal allergic rhinitis did not confirm efficacy findings made in earlier studies. Accordingly, the company is
Actelion provides update on CRTH2 programReuters

all 11 news articles »

View full post on asthma – Google News

Antibiotics increase Severity Of Allergic Asthma – PakTribune.com


Mother Nature Network (blog)

Antibiotics increase Severity Of Allergic Asthma
PakTribune.com
London: Widely used antibiotics may increase incidence and severity of allergic asthma in early life, according to a study. The study, published in the journal EMBO reports, shows that certain antibiotics that affect intestinal bacteria also had a
Study links antibiotics and asthmaMother Nature Network (blog)

all 3 news articles »

View full post on asthma – Google News

Antibiotics increase Severity Of Allergic Asthma – International News Network


Mother Nature Network (blog)

Antibiotics increase Severity Of Allergic Asthma
International News Network
London: Widely used antibiotics may increase incidence and severity of allergic asthma in early life, according to a study. The study, published in the journal EMBO reports, shows that certain antibiotics that affect intestinal bacteria also had a
Study links antibiotics and asthmaMother Nature Network (blog)

all 2 news articles »

View full post on asthma – Google News

Antibotics Linked to Allergic Asthma – CBS42


Mother Nature Network (blog)

Antibotics Linked to Allergic Asthma
CBS42
Allergic asthma affects more than 100 million people worldwide and its prevalence is increasing on average by 50% every decade! A study suggests that widely used antibiotics may be the cause for the increased incidences and severity of allergic asthma
Study links antibiotics and asthmaMother Nature Network (blog)
Antibiotics and Asthma, an Adverse Relationship?dailyRx
Antibiotic treatment increases the severity of asthma in young miceScience Daily (press release)

all 6 news articles »

View full post on asthma – Google News

Antibiotics Linked to Allergic Asthma Increase – Ivanhoe


Mother Nature Network (blog)

Antibiotics Linked to Allergic Asthma Increase
Ivanhoe
(Ivanhoe Newswire) – Allergic asthma affects more than 100 million people worldwide and its prevalence is increasing on average by 50% every decade! A study suggests that widely used antibiotics may be the cause for the increased incidences and
Study links antibiotics and asthmaMother Nature Network (blog)
Antibiotics and Asthma, an Adverse Relationship?dailyRx
Antibiotic treatment increases the severity of asthma in young miceScience Daily (press release)

all 5 news articles »

View full post on asthma – Google News

Antibiotics Use in Children Linked to Severity of Allergic Asthma – UBC Faculty of Science


CBC.ca

Antibiotics Use in Children Linked to Severity of Allergic Asthma
UBC Faculty of Science
Widely used antibiotics may increase incidence and severity of allergic asthma in early life, according to new research from UBC microbiologists. The study, published in the journal EMBO reports, shows that certain antibiotics that affect intestinal
Antibiotic treatment increases the severity of asthma in young miceScience Daily (press release)
Exposure to antibiotics linked to severity of allergic asthma: UBC research (PR)Food Consumer
Kids Exposed To Increased Antibiotics Prone To Allergic AsthmaIBTimes.co.uk
Vancouver Sun –CBC.ca –Mirror.co.uk
all 17 news articles »

View full post on asthma – Google News